U.S. CDC panel backs Pfizer's maternal RSV vaccine to protect infants [Globe and Mail, The (Toronto, Canada)]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Globe and Mail, The
The recommendations will be weighed by new CDC Director Mandy Cohen, who must sign off before the vaccine is distributed. "RSV throughout my career has been a difficult disease with just supportive care treatment because there have been no options so today is an exciting day," said Dr. Katherine Poehling, a member of the panel and a professor of pediatrics and epidemiology and prevention at Wake Forest School of Medicine. The vaccine was approved by the U.S. Food and Drug Administration last month for use during that same window of 32 to 36 weeks into pregnancy to prevent lower respiratory tract infection and severe disease in infants until they are six months old. Getting the vaccine late in pregnancy is likely to reduce a possible risk of preterm births and complications that might arise from taking it earlier, doctors on the panel said. RSV is a common respiratory virus that usually causes mild, cold-like symptoms but can also lead to serious illness and hospitalization. I
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on Pfizer: “I'm Going to Say Just Weak Hold” [Yahoo! Finance]Yahoo! Finance
- BeOne Medicines names R&D chief Wang Lai as co-president to lead global expansion [Yahoo! Finance]Yahoo! Finance
- Better Buy in 2026: Pfizer or Merck? [Yahoo! Finance]Yahoo! Finance
- Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/17/25 - Form 4
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- PFE's page on the SEC website